ANNUAL REVIEW master Final3a - St Vincent's University Hospital
ANNUAL REVIEW master Final3a - St Vincent's University Hospital
ANNUAL REVIEW master Final3a - St Vincent's University Hospital
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>St</strong>. Vincent’s Healthcare Group Limited - Annual Review 2007<br />
Education & Research<br />
To achieve this, of course, close co-operation is required with the clinical team. Dr. Lisa Costelloe was doing<br />
an MD in this area at the Dept of Neurology. Drs. Roisin Lonergan (MS research) and David Bradley<br />
(Dystonia) joined us in July 2007. A new clinic was set up in 2005 specifically for people with MS. In 18<br />
months, almost 500 patients with MS and 150 control subjects have been recruited. Lisa Costelloe, Roisin<br />
Lonergan, Niall Tubridy and Michael Hutchinson assess the patients clinically and document the disease<br />
phenotype in each individual seen. This is done in the course of ‘normal’ clinical care. The work of Katie Doyle,<br />
MS Research Nurse, Sinead Jordan, Research Nurse, and Marguerite Duggan, MS Specialist Nurse, has<br />
been integral to the smooth running of this project and the ongoing care our patients.<br />
We have also undertaken work in collaboration with Dr. Margaret O’Brien looking at OAS in MS and plan<br />
further studies in vitamin D receptor genes in 2008.<br />
In addition to immunological research, we have a long-standing interest in the evaluation of clinical outcome<br />
measures for MS drug trials. In particular, the health related quality of life of MS patients and its quantification<br />
is being examined longitudinally in a large MS cohort attending this hospital. We have established a clinically<br />
useful and psychometrically valid “minimal change score” for one of the widely used MS self–report<br />
instruments. Doctor reported MS rating scales are also being evaluated for clinimetric characteristics that<br />
would make them effective outcome measures for RCTs).<br />
In 2007 and 2008 we plan a large scale study of the epidemiology of MS in Ireland based in Dublin, Donegal<br />
and Wexford. We aim to look at immunological, genetic and vitamin D markers in a large cohort of people<br />
with MS and controls in Ireland.<br />
Current MS Clinical Research Projects of the Neurology Research group<br />
1. Diffusion Tensor Imaging (DTI) of the Medial Longitudinal Fasiculus in Multiple Sclerosis patients<br />
with Internuclear Ophthalmoplegia<br />
To investigate the specificity of DTI, a novel MRI technique that provides information about the direction of<br />
white matter tracts, compared to conventional MRI for detecting disruption of the medial longitudina<br />
fasiculus in MS.<br />
Clinically, superior visualisation of new lesions and axonal loss may be of prognostic value and may<br />
enable us to monitor response to therapy in longitudinal studies.<br />
In collaboration with Jonathan Mc Nulty (Lecturer in Diagnostic Imaging, UCD), Professor Patrick Brennan,<br />
UCD, Professor Powderly, UCD, Dr. Risteard O’Laoide, SVUH<br />
2 Cognitive Functioning in Multiple Sclerosis: a longitudinal ERP analysis to quantify the degree of<br />
mpairment due to MS<br />
In collaboration with Dr. Robert Whelan, PhD Research Fellow Departments of Psychiatry and<br />
Neurology, SVUH.<br />
Cognitive impairment (CI) in MS represents a balance between destruction, repair and<br />
adaptivefunctional reorganisation. Contrast-enhanced MRI often fails to detect diffuse pathological<br />
changes in normal appearing brain tissue. Event Related Potentials (ERP), small fluctuations of the EEG<br />
related to the processing of a relevant stimulus, measure information-processing speed and are the<br />
most robust and sensitive markers of CI in MS. They are sensitive to subtle CI, which influences daily<br />
activities and quality of life, work performance, independent coping skills<br />
Return to Contents<br />
42